This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. A. BUCKWALTER, MD; R. L. LAWTON, MD; R. T. TIDRICK, MD

AMA Arch Surg. 1964;89(2):331-339.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since 1935 when Whipple et al¹ described a procedure for resecting the head of the pancreas, discussion has continued concerning the indications for this operation. That this question remains unresolved is indicated by the differences of opinion expressed by competent surgeons in the current medical literature. At one extreme is the pessimistic view that pancreatoduodenectomy is rarely if ever indicated for treatment of carcinoma of the head of the pancreas.² In contrast is the optimistic view suggesting that the operation should be used to treat carcinoma of the head of the pancreas as well as carcinoma of the ampulla of Vater.³ High operative mortality and postoperative morbidity rates are the principal reasons for the continued caution concerning the indication for this operation. Reported operative mortality rates vary between 6.5%⁴ and 47%.⁵ To justify an operative risk of this magnitude it is necessary to have evidence . . . [Full Text PDF of this Article]

Author Affiliations
IOWA CITY, IOWA

From the departments of surgery, State University of Iowa Hospital, College of Medicine, and Veterans Administration Hospital.

Footnotes
Read before the 21st Annual Meeting of the Central Surgical Association, Rochester, Minn, Feb 27-29, 1964.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?